Abstract
A Percutaneous assist device is commonly used in cardiogenic shock to improve hemodynamics. The Impella provided superior hemodynamic support in the ISAR-SHOCK study compared with an intra-aortic balloon pump (IABP), with no change in clinical outcome. In this trial, the IABP was used in one group, and the Impella was placed in a comparator group. We present a case in which the hemodynamics of cardiogenic shock was assessed in the same patient after IABP and after Impella placement. In our case, the hemodynamics improved after Impella placement and removal of IABP.
Highlights
Cardiogenic shock (CS) is a common cause of death in acute myocardial infarction
We present a case in which the hemodynamics of cardiogenic shock was assessed in the same patient after intra-aortic balloon pump (IABP) and after Impella placement
Reports in the literature have shown that the Impella is better than IABP in hemodynamic improvement; this improvement was found in different patients and not within the same patients
Summary
Cardiogenic shock (CS) is a common cause of death in acute myocardial infarction. It has been reported that the 30-day mortality rate is up to 60-80% in CS [1,2]. A Percutaneous assist device is commonly used in cardiogenic shock to improve hemodynamics. The Impella provided superior hemodynamic support in the ISARSHOCK study compared with an intra-aortic balloon pump (IABP), with no change in clinical outcome. We present a case in which the hemodynamics of cardiogenic shock was assessed in the same patient after IABP and after Impella placement.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
